Muscular Dystrophy (MD) is not a single disease but a group of over 30 genetic conditions, all sharing one defining feature: progressive muscle weakness caused by faulty genes. At the core of every MD diagnosis is a story written in DNA – a story of mutations, proteins, and inheritance patterns that determine how severely the condition presents and who is most at risk. Understanding what causes MD starts with understanding what goes wrong at the genetic level.
Table of Contents
- What genes have to do with muscle health
- The role of gene mutation in muscular dystrophy
- Types of mutations that occur
- Inheritance: how MD runs in families
- X-linked inheritance and the carrier phenomenon
- Inheritance probability for families
- When there is no family history: spontaneous mutations
- No environmental cause
- Why the same mutation can look different in different people
- Genetic testing and what it means for families
What genes have to do with muscle health
Muscles don’t just work on willpower – they depend on a precise set of proteins to stay structurally intact and function properly. These proteins are produced according to instructions encoded in genes. According to the National Institute of Neurological Disorders and Stroke, most cases of MD are caused by gene changes that affect muscle proteins. When a protein is changed or the body doesn’t produce enough of it, muscle cells can no longer do their job.
One of the most critical of these proteins is dystrophin. As described by MedlinePlus Genetics, dystrophin is part of a group of proteins that work together to strengthen muscle fibers and protect them from injury as muscles contract and relax. It acts as an anchor – connecting each muscle cell’s internal framework to the surrounding tissue matrix. Without sufficient functional dystrophin, muscle cells sustain repeated damage every time the muscle moves, gradually weakening and dying over time.
The role of gene mutation in muscular dystrophy
The National Institute of Child Health and Human Development (NICHD) explains that MD is caused by gene mutations that affect proteins in muscles. These mutations interfere with the body’s ability to produce functional muscle-supporting proteins, triggering the slow deterioration of muscle fibers that defines the condition.
In the most common forms – Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD) – the affected gene is the DMD gene, located on the X chromosome. Parent Project Muscular Dystrophy describes the DMD gene as essentially a recipe for making the dystrophin protein, which acts as a shock absorber, allowing muscles to contract and relax without being damaged. When there are changes (called variants) in the DMD gene, it leads to differences in the amount, size, or function of the dystrophin protein – and without enough functional dystrophin, muscles cannot repair themselves.
Types of mutations that occur
Not all mutations are the same. MedlinePlus Genetics notes that most mutations in the DMD gene involve deletions of part of the gene, while others involve abnormal duplications or small-scale changes to DNA building blocks. The type of mutation matters greatly for the severity of the condition. Mutations that prevent any functional dystrophin from being produced tend to cause the more severe Duchenne MD, while mutations that allow a shortened but partially functional dystrophin to be made are more commonly associated with the milder Becker form.
Other forms of MD involve mutations in completely different genes and proteins. A review published in PMC highlights that myotonic dystrophy – the most common adult form of MD – results from an abnormal expansion of repeated DNA sequences in a gene, rather than a deletion. This shows how diverse the genetic mechanisms behind MD can be, even though the end result is always progressive muscle weakness.
Inheritance: how MD runs in families
Because MD is rooted in genetics, it frequently runs in families. The way it is passed down, however, depends on which gene is affected and where that gene sits in the genome. NICHD outlines three main inheritance patterns for MD: autosomal dominant (where one copy of the mutated gene from one parent is enough to cause the disease), autosomal recessive (where both copies of a gene must be mutated), and X-linked recessive (where the mutation is carried on the X chromosome).
The X-linked pattern is particularly important because it explains why certain forms of MD – especially DMD and BMD – affect males far more often and more severely than females.
X-linked inheritance and the carrier phenomenon
To understand X-linked inheritance, a brief note on chromosomes is essential. Humans have 23 pairs of chromosomes, including a pair of sex chromosomes. The National Human Genome Research Institute explains that females have two X chromosomes (XX), while males have one X and one Y chromosome (XY). The DMD gene sits on the X chromosome.
This biological difference has a direct impact on who develops MD and how severely. When a female has a DMD mutation on one of her two X chromosomes, she has a second, functioning X chromosome that can produce enough dystrophin to protect her from developing the full disease. She is called a carrier. According to the NHGRI, most carriers are unaware they carry the mutation unless they have a family history – though approximately 20% of female carriers may show some symptoms, including muscle weakness and cardiac abnormalities.
Males, on the other hand, have only one X chromosome. If that single X chromosome carries a DMD mutation, there is no backup copy. MedlinePlus Genetics explains that in males, one altered copy of the gene in each cell is sufficient to cause the condition, which is why Duchenne and Becker MD occur almost exclusively in males.
Inheritance probability for families
When a mother is a carrier of a DMD mutation, each pregnancy carries specific statistical risks. The Muscular Dystrophy Association (MDA) explains that each son has a 50% chance of inheriting the mutation and having DMD, while each daughter has a 50% chance of inheriting the mutation and becoming a carrier herself. This means a family can be affected across multiple generations, even if the carrier females in the family have no noticeable symptoms.
Males with DMD cannot pass the condition to their sons (since sons inherit the Y chromosome from their father), but all of their daughters will inherit the mutated X chromosome, making every daughter a carrier.
When there is no family history: spontaneous mutations
One of the more surprising aspects of MD is that it doesn’t always follow a clear family history. Parent Project Muscular Dystrophy reports that approximately 30% of children born with Duchenne have a genetic change that started in them and was not inherited – called a spontaneous or de novo variant.
Muscular Dystrophy News clarifies that de novo mutations happen by chance – occurring in an egg or sperm cell from a parent, or directly in the cells of a fertilized egg after conception. There is no way to predict them and no parental action causes them. Crucially, once a spontaneous mutation occurs in one person, it can then be passed on to their children following the typical X-linked inheritance pattern.
There is also another reason why families may appear to have no history of MD even when the mutation has been present for generations: the MDA notes that the genetic mutation may have existed in female family members for several generations without detection – particularly if no male children were born in those generations to express the condition.
No environmental cause
It is worth emphasizing clearly: as confirmed by NINDS, MD is not contagious and cannot be caused by injury or physical activity. The cause is always genetic – whether inherited or arising spontaneously. This distinction matters enormously for families navigating a diagnosis, as it removes any question of personal responsibility or environmental trigger.
Why the same mutation can look different in different people
Even within a family, MD does not always present identically. The same type of mutation can result in varying degrees of severity depending on additional genetic factors and the precise location of the change in the gene. Cleveland Clinic notes that how quickly symptoms progress varies based on the type of MD – and even within a given type, progression is not always uniform.
In female carriers, a process called X-inactivation – where one of the two X chromosomes in each cell is randomly silenced – can further affect how much of the disease a carrier experiences. A StatPearls review on NIH explains that in females with Duchenne MD, an error in somatic cells can lead to the inactivation of the healthy X chromosome in a portion of cells, creating what is called a mosaic pattern of healthy and affected muscle, which can sometimes cause symptoms in otherwise carrier females.
Genetic testing and what it means for families
Because the genetic basis of MD is now well understood, genetic testing has become the most definitive way to confirm a diagnosis, identify carriers, and guide family planning. Muscular Dystrophy News explains that genetic testing involves analyzing a person’s DNA – typically from a blood or saliva sample – to identify disease-causing mutations in the relevant gene. It can also reveal whether someone is a carrier before they have children.
For educators, support workers, and caregivers working alongside individuals with MD or their families, understanding that this is a condition written into a person’s genetic code – not caused by lifestyle or environment – helps build a more accurate and compassionate understanding of the condition. The genetic complexity behind MD is not a simple story of “bad genes,” but rather a nuanced interplay of inheritance, chance mutations, chromosomal biology, and protein function.
What do you think? Given that around one in three DMD cases arise from spontaneous mutations with no family history, how might this change the way schools and support services communicate diagnosis information to newly affected families? And considering that female carriers may carry the mutation without any noticeable symptoms, what role should genetic counselling play as part of broader disability awareness education?
References
- https://www.ninds.nih.gov/health-information/disorders/muscular-dystrophy
- https://medlineplus.gov/genetics/gene/dmd/
- https://www.nichd.nih.gov/health/topics/musculardys/conditioninfo/causes
- https://www.parentprojectmd.org/about-duchenne/what-is-duchenne/genetic-causes/
- https://medlineplus.gov/genetics/condition/duchenne-and-becker-muscular-dystrophy/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4496952/
- https://www.genome.gov/Genetic-Disorders/Duchenne-Muscular-Dystrophy
- https://www.mda.org/disease/duchenne-muscular-dystrophy/causes-inheritance
- https://www.parentprojectmd.org/care/for-carriers/inheritance/
- https://musculardystrophynews.com/causes/
- https://my.clevelandclinic.org/health/diseases/14128-muscular-dystrophy
- https://www.ncbi.nlm.nih.gov/books/NBK560582/
- https://musculardystrophynews.com/duchenne-muscular-dystrophy-genetics-inheritance/
Leave a Reply